FRANCIS KNUETTEL II (Interim CEO, CFO, Treas & Sec) purchased 2.3% of their position (12K shares) of PELTHOS THERAPEUTICS INC. on the open market
Open‑market purchase worth $11.0K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/12/2024ACC: 0001753926-24-001570
Officer· Interim CEO, CFO, Treas & Sec
Since Feb 2024
+12K
Net shares
Net buyer
$11.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
12K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+6.50K
Price / share
$0.89
Trade value
$5.79K
% of position
1.2%
9/10/2024
530.51K→537.01K
Common Stock
Indirect
Shares
+5.50K
Price / share
$0.94
Trade value
$5.17K
% of position
1.0%
9/11/2024
537.01K→542.51K
Total
Net shares
+12K
Net value
$10.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/10/2024 | P · Purchase | +6.50K | $0.89 | $5.79K | 1.2% | 530.51K | 537.01K |
| Common Stock Indirect | 9/11/2024 | P · Purchase | +5.50K | $0.94 | $5.17K | 1.0% | 537.01K | 542.51K |
| Total | +12K | $10.96K | ||||||
Derivative Transactions0
No derivative transactions reported